Karius is a life sciences company that uses genomics and artificial intelligence to advance infectious disease diagnostics. Their primary offering is the Karius Test, a liquid biopsy that can detect over 1,000 pathogens from a single blood sample.
Under the 'Generative AI Integrations' section, the posting states: 'Implement generative AI solutions to increase the value and usability of Karius data assets across use-cases such as data pipelining, data discovery, knowledgebase search, and conversational analytics,' which is a clear signal of implementing new AI-driven software.